Omamalin, Jean C.
HRN: 21-28-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2022
CEFUROXIME 1.5GM (VIAL)
08/20/2022
08/21/2022
IV
1.5gm
Q8 X 3 More Doses
S/P CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes